%0 Journal Article
%T Comparison the efficacy of ceftazidime and imipenem in treatment of neutropenic febrile due to chemotherapy in cancer patients
%A Zahra fotokian
%A Shahrbanoo Keihanian
%A Fatemeh ghaffari
%A Neda khabiri
%J Koomesh
%D 2009
%I Semnan Univeristy of Medical Sciences
%X Introduction: In cancer patients various infections were developed due to severe neutropeniaresulted from chemotherapy. There is controversy between initial monotherapy or multidrugprescription. The purpose of this study was to compare the efficacy of ceftazidime and imipenem incontrol of fever in cancer patients with febrile neutropenia.Materials ands Methods: 40 patients with cancer, fever and neutropenia (PMN<500), withoutrecognized source of infection, were selected using the convenience and consecutive method. Using arandom sampling, twenty patients were treated with imipenem (500mg Iv/Q8hr) and others withceftazidime (2mg Iv/Q8hr). The criteria for positive response to the drugs were: fever disappearanceduring maximally 72 hours lasted for up to 24 hours, and increased neutrophil counts more than500/ml.Results: Our results show that 60% and 55% patients with ceftazidime and imipenem were cured,respectively. 40% patients treated with ceftazidime and 45% patients treated with imipenem neededanother antibiotic therapy at the same time. No significant relationship was found between differenttypes of drug regime among the groups.Conclusion: Findings of this study indicate that ceftazidime and imipenem have similar efficacy intreatment of febrile neutropenic patients. Due to more availability and lower cost of ceftazidime thanimipenem, ceftazidime is suggested as first line treatment in febrile neutropenia.
%K Febrile neutropenia
%K Ceftazidime
%K Imipenem
%K Cancers
%K Chemotherapy
%U http://www.koomeshjournal.ir/browse.php?a_code=A-10-4-381&slc_lang=en&sid=1&ftxt=1